What is the recommended first‑line treatment for an uncomplicated urinary tract infection in an otherwise healthy adult?

First-Line Treatment for Uncomplicated UTI

For an otherwise healthy adult with uncomplicated urinary tract infection, prescribe nitrofurantoin 100 mg orally twice daily for 5 days as the preferred first-line therapy. This regimen achieves approximately 93% clinical cure and 88% microbiological eradication while maintaining worldwide resistance rates below 1%. 1, 2

Defining Uncomplicated UTI

Before selecting therapy, confirm the infection is truly uncomplicated by verifying the absence of fever, flank pain, pregnancy, indwelling catheter, immunosuppression, diabetes, recent urinary instrumentation, or male sex. 2 The presence of any of these factors requires a different treatment approach.

Complete First-Line Options (Choose One)

Option 1: Nitrofurantoin (Preferred)

• Nitrofurantoin 100 mg orally twice daily for 5 days 1, 2
• Provides 93% clinical cure and 88% microbiological eradication 2
• Causes minimal disruption to intestinal flora, reducing C. difficile risk 2
• Contraindication: Do not use if eGFR < 30 mL/min/1.73 m² 2
• Contraindication: Do not use for suspected pyelonephritis 1, 2

Option 2: Trimethoprim-Sulfamethoxazole (TMP-SMX)

• TMP-SMX 160/800 mg (one double-strength tablet) orally twice daily for 3 days 1, 2
• Achieves 93% clinical cure and 94% microbiological eradication when susceptible 2
• Use ONLY when BOTH criteria are met: 1, 2
  • Local E. coli resistance is documented < 20%
  • Patient has NOT received TMP-SMX in the preceding 3 months
• Critical pitfall: Prescribing TMP-SMX without confirming local resistance < 20% leads to unacceptably high failure rates 2

Option 3: Fosfomycin

• Fosfomycin tromethamine 3 g as a single oral dose 1, 2, 3
• Provides approximately 91% clinical cure 2
• Maintains therapeutic urinary concentrations for 24-48 hours 2
• Resistance rates only 2.6% in initial infections 2
• Mix with 90-120 mL water before ingesting; do not take in dry form 3
• Contraindication: Do not use for suspected pyelonephritis or upper-tract infections due to insufficient tissue penetration 2

When to Obtain Urine Culture

Routine urine culture is NOT required for otherwise healthy adults with typical lower-tract symptoms (dysuria, frequency, urgency) and no vaginal discharge. 2, 4

Obtain urine culture and susceptibility testing when: 2

• Symptoms persist after completing therapy
• Symptoms recur within 2-4 weeks
• Fever > 38°C, flank pain, or costovertebral angle tenderness (suggests pyelonephritis)
• Atypical presentation or vaginal discharge present
• History of recurrent infections or prior resistant organisms
• Pregnancy

Reserve (Second-Line) Agents – Use Only When First-Line Fails

Fluoroquinolones (Culture-Directed Only)

• Ciprofloxacin 250-500 mg twice daily for 3 days OR levofloxacin 250-750 mg once daily for 3 days 1, 2
• Reserve exclusively for culture-proven resistant pathogens or documented failure of first-line agents 2
• The 2016 FDA advisory recommends against fluoroquinolone use for uncomplicated UTIs because serious adverse effects (tendon rupture, peripheral neuropathy, CNS toxicity) outweigh benefits 2
• Global resistance exceeds 10% in many regions 2

Beta-Lactams (Inferior Efficacy)

• Amoxicillin-clavulanate, cefdinir, or cefpodoxime for 3-7 days 1, 2
• Achieve only 89% clinical cure and 82% microbiological eradication—significantly inferior to first-line agents 1, 2
• Use only when all first-line options are contraindicated 2
• Never use amoxicillin or ampicillin alone: worldwide E. coli resistance exceeds 55-67% 1, 2

Management of Treatment Failure

If symptoms persist after 2-3 days or recur within 2 weeks: 2

1. Obtain urine culture and susceptibility testing immediately 2
2. Switch to a different antibiotic class for a full 7-day course (not the original short regimen) 2
3. Assume the original pathogen is resistant to the first agent 2

Example switches: 2

• If nitrofurantoin failed → switch to TMP-SMX (if local resistance < 20%)
• If TMP-SMX failed → switch to nitrofurantoin or fosfomycin
• Reserve fluoroquinolones only for culture-proven resistance 2

Critical Pitfalls to Avoid

• Do NOT treat asymptomatic bacteriuria in non-pregnant, non-catheterized adults—this promotes resistance without clinical benefit 2
• Do NOT use empiric fluoroquinolones as first-line therapy for uncomplicated cystitis 2
• Do NOT prescribe TMP-SMX without confirming local E. coli resistance < 20% 2
• Do NOT use nitrofurantoin when eGFR < 30 mL/min/1.73 m² or for suspected pyelonephritis 2
• Do NOT use oral fosfomycin for suspected upper-tract infection 2
• Do NOT repeat the same antibiotic that failed initially—assume resistance and switch classes 2

Special Populations

Pregnancy

• First-line: Nitrofurantoin 100 mg twice daily for 5-7 days, fosfomycin 3 g single dose, or amoxicillin 500 mg three times daily for 3-7 days 5
• Avoid: Fluoroquinolones throughout pregnancy; TMP-SMX in first and third trimesters 5
• Always obtain urine culture before and after treatment 5

Breastfeeding

• Nitrofurantoin 100 mg twice daily for 5 days is the safest option with minimal infant exposure 2
• Fosfomycin and TMP-SMX are also compatible with breastfeeding 2

Elderly (≥65 years)

• Same first-line agents and durations as younger adults 4
• Obtain urine culture to guide therapy adjustment after initial empiric treatment 4